Page 13 - Genetic Engineering in Health Care - Hi-Tech Health Care
P. 13
INDEX
Berg, Paul, 21–22, 24–25 Kornberg, Arthur, 17–20
cancer, 21, 39, 58–59, 64–67 Mendel, Gregor, 20
CAR T-cell therapy, 58–59 messenger RNA (mRNA), 52–54
COVID-19 pandemic, 48–50, mutations, 8, 31–32, 61
52–57
CRISPR-Cas9, 25–27, 41–43, 60, oncolytic virus therapy, 64–67
62–64, 66, 68, 72 personalized medicine, 63
DNA, 10–12, 14–24, 26, 31, 33–36, Petri, William, 54
39–43, 46, 48, 57, 66, 67–68 Photo 51, 15–17
Doudna, Jennifer, 25, 64 proteins, 8, 12, 34, 36, 48, 49, 51,
52–54, 57
embryos, 68, 71–72
enzymes, 17–18, 20, 34, 40–42 recombinant DNA (rDNA), 22–24,
ethical issues, 68–72 34, 45, 47
RNA, 42, 49, 52–54
Franklin, Rosalind, 15–16
sickle cell disease, 60–62
gene drives, 66 stem cells, 38
gene editing, 39–40
vaccines, 24, 44, 50–57
He Jiankui, 71–72 viruses, 21–22, 36–37, 41, 42,
Human Genome Project, 28–31 48–49, 55–57, 58, 64–67
immune system, 8–10, 46, 50–51,
54, 57, 65–66
insulin, 45–47
78
